by PEPID Newsroom | Apr 3, 2019 | Alerts
The US FDA approved Cimzia (certolizumab pegol) injection for treatment of adults with non-radiographic axial spondyloarthritis (nr-axSpA), a type of inflammatory arthritis. This is the first fda approved treatment for nr-axSpA. Nr-axSpA causes inflammation in the...
by PEPID Newsroom | Apr 2, 2019 | Alerts
Mayzent (siponimod) The FDA approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Mayzent was shown to be...
by PEPID Newsroom | Apr 1, 2019 | Alerts
Six outbreaks, defined as three or more cases of Measles (Rubeola), are currently ongoing within: New York State, Rockland County New York City Washington California, Santa Cruz County New Jersey California, Butte County There have been 387 confirmed individual cases...
by Megan Pullins | Apr 1, 2019 | Primary Care
Life-saving Potential As a trusted health professional, your words on the topic can greatly impact perspectives on being an organ donor, help see through myths, and, at the very least, help people remember that donating is important. A single organ donor can save up...
by PEPID Newsroom | Mar 29, 2019 | Alerts
[elfsight_social_share_buttons id=”3″] Jatenzo, (testosterone undecanoate) has been given the FDA greenlight to be used as an oral capsule treatment for men with certain forms of hypogonadism. Jatenzo is the first treatment option for men with certain...
by PEPID Newsroom | Mar 28, 2019 | Alerts
Influenza activity, particularly caused by the A(H3N2) virus, remains elevated across the US. The CDC has released a health advisory, reminding clinicians to keep influenza top of mind when diagnosing patients with respiratory illness. The report contains several...
by Anna Tan | Mar 26, 2019 | Primary Care
1 in 4 Adults are Still Unaware That They are Living with Diabetes. For how seriously debilitating and life-altering diabetes can be for about 30.3 million diagnosed Americans, the American Diabetes Association (ADA) estimates that nearly 1 in 4 adults, or 7.2 million...
by PEPID Newsroom | Mar 25, 2019 | Alerts
Multiple states across the U.S. have reported hepatitis A outbreaks among people who use drugs and people experiencing homelessness. Since the initial awareness of the outbreak in 2016, there have been more than 15,000 cases with 57% in need of hospitalizations, and...
by PEPID Newsroom | Mar 21, 2019 | Alerts
The FDA approved the Optimizer Smart system for patients with chronic, moderate-to-severe heart failure who are not suited for treatment with other heart failure devices such as cardiac re-synchronization therapy to restore a normal heartbeat timing pattern. The...
by Anna Tan | Mar 20, 2019 | Alerts
FDA Approves Spravato (esketamine) nasal spray to treat treatment-resistant depression in adults, but is only available at certified doctor’s offices and clinics. Treatment-resistant patients are adults with major depressive disorder, who have tried a minimum of two...
